4.03

0.50% 0.02

After Hours: 4.02 -0.01 -0.25%

Collplant Biotechnologies Ltd (CLGN)

Overview News Price History Option Chain Discussions Forecast

Collplant Biotechnologies Ltd stock is traded at $4.03, with a volume of 2,340. It is up +0.50% in the last 24 hours and up +10.71% over the past month. CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Previous Close:

$4.01

Open:

$4.1

24h Volume:

2,340

Relative Volume:

0.17

Market Cap:

$46.16M

Revenue:

$10.96M

Net Income/Loss:

$-7.02M

P/E Ratio:

-6.2969

EPS:

-0.64

Net Cash Flow:

$-3.72M

1W Performance:

-4.01%

1M Performance:

+10.71%

6M Performance:

-20.04%

1Y Performance:

-24.39%

1-Day Range:

$4.00

$4.15

1-Week Range:

$3.79

$4.31

52-Week Range:

$3.24

$6.75

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name

Collplant Biotechnologies Ltd

Sector

Healthcare (1174)

Industry

Biotechnology (684)

Phone

Address

Employee

Twitter

@CollplantBio

Next Earnings Date

2024-12-27

Latest SEC Filings

CLGN's Discussions on Twitter

Compare CLGN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLGN Collplant Biotechnologies Ltd	4.03	46.16M	10.96M	-7.02M	-3.72M	-0.64
VRTX Vertex Pharmaceuticals Inc	422.00	108.68B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	681.58	74.90B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	640.52	38.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	246.27	31.76B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	111.93	26.83B	3.30B	-501.07M	1.03B	-2.1146

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-17-23	Initiated	Alliance Global Partners	Buy

Collplant Biotechnologies Ltd Stock (CLGN) Latest News

01:42 AM

Contrasting CollPlant Biotechnologies (NASDAQ:CLGN) and Pathfinder Cell Therapy (OTCMKTS:PFND) - Defense World

01:42 AM

Dec 24, 2024

Collplant stock hits 52-week low at $3.24 amid market challenges By Investing.com - Investing.com South Africa

Dec 24, 2024

Dec 23, 2024

Collplant stock hits 52-week low at $3.24 amid market challenges - Investing.com India

Dec 23, 2024

Dec 01, 2024

CLGN (CollPlant Biotechnologies) 50-Day SMA : $4.31 (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024

Nov 30, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2024 Earnings Call Transcript - MSN

Nov 30, 2024

Nov 28, 2024

CLGNCollPlant Biotechnologies Ltd Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nov 28, 2024

CollPlant Biotechnologies Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 28, 2024